{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:21:19Z","timestamp":1765808479976,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Newborn screening (NBS) for inherited metabolic diseases (IMD) aims to find children in which immediate action can prevent severe symptoms. We previously studied parental satisfaction with the communication of the NBS result for phenylketonuria, which in the Netherlands is done by the general practitioners (GPs). More than half of all parents were unsatisfied with the communication of the abnormal NBS result. The aim of this qualitative exploratory study was to portray a number of GPs\u2019 opinions and experiences in communicating an abnormal metabolic NBS result. We performed semi-structured interviews with ten GPs to evaluate the process of communicating the abnormal NBS result. An additional two GPs provided their answers via email. The data revealed four key themes: (1) dealing with the urgency of the metabolic NBS result, (2) the role of the GP in the NBS process, (3) the current organization of NBS in the Netherlands and (4) evaluating roles and responsibilities in communicating abnormal metabolic NBS results. Despite the willingness of GPs to inform parents about NBS results, it is questionable whether they have the necessary tools to effectively conduct these conversations given their limited experience with IMDs. In light of the increasing number of diseases in the NBS program, it would be interesting to explore alternative tools for communicating the NBS result to parents.<\/jats:p>","DOI":"10.3390\/ijns11030062","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:41:53Z","timestamp":1754653313000},"page":"62","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Communication of an Abnormal Metabolic Newborn Screening Result in the Netherlands: A Qualitative Exploratory Study of the General Practitioner\u2019s Perspective"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-6454","authenticated-orcid":false,"given":"Sietske","family":"Haitjema","sequence":"first","affiliation":[{"name":"Department of Metabolic Diseases, Beatrix Children\u2019s Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte M. A.","family":"Lubout","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Beatrix Children\u2019s Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine H. M.","family":"Zijlstra","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Beatrix Children\u2019s Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rendelien K.","family":"Verschoof-Puite","sequence":"additional","affiliation":[{"name":"Department of Vaccine Supply and Prevention Programmes, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3773-1929","authenticated-orcid":false,"given":"Francjan J.","family":"van Spronsen","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Beatrix Children\u2019s Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","unstructured":"(2025, July 03). De Historie van de Hielprikscreening\u2014Draaiboek Hielprikscreening RIVM. Available online: https:\/\/draaiboekhielprikscreening.rivm.nl\/over-nhs\/de-historie-van-de-hielprikscreening."},{"key":"ref_2","unstructured":"(2023, October 30). Clinical Picture\u2014Prenatale En Neonatale Screeningen. Available online: https:\/\/www.pns.nl\/node\/7171."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10545-012-9483-0","article-title":"Newborn Screening Programmes in Europe; Arguments and Efforts Regarding Harmonization. Part 1\u2014From Blood Spot to Screening Result","volume":"35","author":"Loeber","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_4","unstructured":"(2023, October 30). Organisation\u2014Prenatale En Neonatale Screeningen. Available online: https:\/\/www.pns.nl\/hielprik\/professionals\/organisatie."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ejhg.2014.126","article-title":"Parents\u2019 Responses to Receiving Sickle Cell or Cystic Fibrosis Carrier Results for Their Child Following Newborn Screening","volume":"23","author":"Ulph","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0009922812446011","article-title":"Newborn Screening for Metabolic Disorders: Parental Perceptions of the Initial Communication of Results","volume":"51","author":"Buchbinder","year":"2012","journal-title":"Clin. Pediatr."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"van den Heuvel, L.M., van der Pal, S.M., Verschoof-Puite, R.K., Klapwijk, J.E., Elsinghorst, E., Dekkers, E., van der Ploeg, C.P.B., and Henneman, L. (2024). Psychosocial Impact of a True-Positive, False-Positive, or Inconclusive Newborn Bloodspot Screening Result: A Questionnaire Study Among Parents. Int. J. Neonatal Screen., 10.","DOI":"10.3390\/ijns10010018"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e037081","DOI":"10.1136\/bmjopen-2020-037081","article-title":"Qualitative Exploration of Health Professionals\u2019 Experiences of Communicating Positive Newborn Bloodspot Screening Results for Nine Conditions in England","volume":"10","author":"Chudleigh","year":"2020","journal-title":"BMJ Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e050773","DOI":"10.1136\/bmjopen-2021-050773","article-title":"Process Evaluation of Co-Designed Interventions to Improve Communication of Positive Newborn Bloodspot Screening Results","volume":"11","author":"Chudleigh","year":"2021","journal-title":"BMJ Open"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Haitjema, S., Lubout, C.M.A., Zijlstra, J.H.M., Wolffenbuttel, B.H.R., and van Spronsen, F.J. (2022). Communication of an Abnormal Metabolic New-Born Screening Result in The Netherlands: The Parental Perspective. Nutrients, 14.","DOI":"10.3390\/nu14193961"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using Thematic Analysis in Psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual. Res. Psychol."},{"key":"ref_12","first-page":"37","article-title":"The Use of Saturation in Qualitative Research","volume":"22","author":"Walker","year":"2012","journal-title":"Can. J. Cardiovasc. Nurs."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bush, L.W., and Levy, H.L. (2024). Past as Prologue: Predicting Potential Psychosocial-Ethical Burdens of Positive Newborn Screens as Conditions Propagate. Int. J. Neonatal Screen., 10.","DOI":"10.3390\/ijns10010012"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10897-016-9959-4","article-title":"Parents\u2019 Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease","volume":"25","author":"Chudleigh","year":"2016","journal-title":"J. Genet. Couns."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pec.2011.12.007","article-title":"Factors That Influence Parents\u2019 Experiences with Results Disclosure After Newborn Screening Identifies Genetic Carrier Status for Cystic Fibrosis or Sickle Cell Hemoglobinopathy","volume":"90","author":"Collins","year":"2013","journal-title":"Patient Educ. Couns."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10875-020-00886-4","article-title":"Parents\u2019 Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands","volume":"41","author":"Blom","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcf.2015.12.003","article-title":"Newborn Screening for Cystic Fibrosis \u2014The Parent Perspective","volume":"15","author":"Rueegg","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0009922814545619","article-title":"Primary Care Providers\u2019 Experiences Notifying Parents of Cystic Fibrosis Newborn Screening Results","volume":"54","author":"Finan","year":"2015","journal-title":"Clin. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.46747\/cfp.6706439","article-title":"Primary Care Providers\u2019 Role in Newborn Screening Result Notification for Cystic Fibrosis","volume":"67","author":"Hayeems","year":"2021","journal-title":"Can. Fam. Physician"},{"key":"ref_20","first-page":"7","article-title":"Living with Phenylketonuria from the Point of View of Children, Adolescents, and Young Adults: A Qualitative Study","volume":"33","author":"Forcella","year":"2012","journal-title":"Behav. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine Hydroxylase Deficiency: Diagnosis and Management Guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"key":"ref_22","unstructured":"UK Health Security Agency, GOV.UK (2025, July 03). A Laboratory Guide to Newborn Blood Spot Screening for Inherited Metabolic Diseases, Available online: https:\/\/www.gov.uk\/government\/publications\/newborn-blood-spot-screening-laboratory-guide-for-imds\/a-laboratory-guide-to-newborn-blood-spot-screening-for-inherited-metabolic-diseases."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcf.2019.04.004","article-title":"International Approaches for Delivery of Positive Newborn Bloodspot Screening Results for CF","volume":"18","author":"Chudleigh","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10545-012-9484-z","article-title":"Newborn Screening Programmes in Europe; Arguments and Efforts Regarding Harmonization. Part 2\u2014From Screening Laboratory Results to Treatment, Follow-Up and Quality Assurance","volume":"35","author":"Burgard","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_25","first-page":"38","article-title":"Redefining the Core Values and Tasks of GPs in the Netherlands (Woudschoten 2019)","volume":"70","year":"2019","journal-title":"Br. J. Gen. Pract."},{"key":"ref_26","first-page":"A7532","article-title":"Transferring Care from Secondary to Primary Health Services; Time for Action","volume":"158","author":"Damoiseaux","year":"2014","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"ref_27","unstructured":"Lawrence, W. (2011). Neuman Social Research Methods: Qualitative and Quantitative Approaches, Allyn & Bacon. [7th ed.]."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1609406919899220","DOI":"10.1177\/1609406919899220","article-title":"Intercoder Reliability in Qualitative Research: Debates and Practical Guidelines","volume":"19","author":"Joffe","year":"2020","journal-title":"Int. J. Qual. Methods"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Braun, V., and Clarke, V. (2021). Thematic Analysis: A Practical Guide, SAGE.","DOI":"10.1007\/978-3-319-69909-7_3470-2"}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/11\/3\/62\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:24Z","timestamp":1760034384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/11\/3\/62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijns11030062"],"URL":"https:\/\/doi.org\/10.3390\/ijns11030062","relation":{},"ISSN":["2409-515X"],"issn-type":[{"type":"electronic","value":"2409-515X"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}